Prof. He Wang 王鹤
Chief Physician, Professor
Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Nanning
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Uterine fibroids, endometriosis, cervical cancer, ovarian tumors, endometrial cancer, and choriocarcinoma.
Dr. Wang holds a medical doctorate and serves as a Chief Physician and master’s supervisor. The doctor focuses on clinical and basic research in gynecologic oncology, specializing in laparoscopic and open surgery, radiotherapy, and chemotherapy for malignant tumors. Training includes fellowships at Peking Union Medical College Hospital, Southwest Hospital, the Academy of Military Medical Sciences, and McGill University Health Centre in Canada.
Name order: in Chinese the family name comes first (Wang He). Papers usually list the name as He Wang or Wang H.
Selected publications
14 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Oncol Lett, 2026 (senior author): Anti-CD20 and -PD-1 antibody effects on proliferation, apoptosis and cell cycle of endometrial cancer cells. PubMed 42375167
- BMC Biotechnol, 2026 (senior author): Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy. PubMed 42337528
- BMC Microbiol, 2025 (senior author): The mechanism of ECT1/E6E7 cervical intraepithelial neoplasia cells regulated by Acinetobacter lwoffii through circ-LDHA/HMGB1. PubMed 40414884
- Int J Gen Med, 2022 (senior author): Predict the Progression of Cervical Intraepithelial Neoplasia by a Novel Marker Folate Combine with FRα, p16 and Ki-67. PubMed 35971526
- BMC Cancer, 2022 (first author): Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia. PubMed 35379200
- Infect Agent Cancer, 2022 (senior author): Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine. PubMed 35197089
- Int J Gen Med, 2022 (senior author): SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer. PubMed 35221714
- Infect Agent Cancer, 2019 (senior author): Correction to: A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia. PubMed 31827598
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion